Irland - engelska - HPRA (Health Products Regulatory Authority)

ferring ireland ltd - desmopressin acetate - tablet - 0.1 milligram(s) - vasopressin and analogues; desmopressin

Irland - engelska - HPRA (Health Products Regulatory Authority)

ferring ireland ltd - desmopressin acetate - solution for injection - 4 microgram(s)/millilitre - vasopressin and analogues; desmopressin

Malta - engelska - Medicines Authority

ferring pharmaceuticals limited - desmopressin acetate - nasal drops, solution - desmopressin acetate 100 µg/ml - pituitary and hypothalamic hormones and analogues

Kanada - engelska - Health Canada

rainbow pharmaceuticals inc - desmopressin acetate - tablet - 0.1mg - desmopressin acetate 0.1mg - pituitary

Kanada - engelska - Health Canada

rainbow pharmaceuticals inc - desmopressin acetate - tablet - 0.2mg - desmopressin acetate 0.2mg - pituitary

USA - engelska - NLM (National Library of Medicine)

sun pharmaceutical industries, inc. - desmopressin acetate (unii: xb13hyu18u) (desmopressin - unii:enr1llb0fp) - desmopressin acetate nasal solution 0.01% (nasal spray) is indicated as antidiuretic replacement therapy in the management of central diabetes insipidus in adults and pediatric patients 4 years of age and older. limitations of use: desmopressin acetate nasal solution 0.01% (nasal spray) is not indicated for: • treatment of nephrogenic diabetes insipidus, • treatment of primary nocturnal enuresis [see warnings and precautions (5.1)], • use in patients with conditions that compromise the intranasal route of administration (e.g., severe nasal congestion and blockage, nasal mucosa atrophy, severe atrophic rhinitis, recent nasal surgery such as transsphenoidal hypophysectomy) [see warnings and precautions (5.2)]. • use in patients with an impaired level of consciousness, • use in patients requiring doses less than 10 mcg or doses that are not multiples of 10 mcg [see dosage forms and strengths (3)]. desmopressin acetate nasal solution 0.01% (nasal spray) is contraindicated in patients with: • known hypersens

USA - engelska - NLM (National Library of Medicine)

dr. reddy's laboratories inc. - desmopressin acetate (unii: xb13hyu18u) (desmopressin - unii:enr1llb0fp) - desmopressin acetate injection is indicated as antidiuretic replacement therapy in the management of central (cranial) diabetes insipidus and for the management of the temporary polyuria and polydipsia following head trauma or surgery in the pituitary region. limitations of use: desmopressin acetate injection is ineffective and not indicated for the treatment of nephrogenic diabetes insipidus. desmopressin acetate injection is indicated for patients with hemophilia a with factor viii coagulant activity levels greater than 5% without factor viii antibodies to: - maintain hemostasis during surgical procedures and postoperatively - reduce bleeding with episodes of spontaneous or traumatic injuries such as hemarthroses, intramuscular hematomas, or mucosal bleeding. desmopressin acetate injection is indicated for patients with mild to moderate von willebrand’s disease (type i) with factor viii levels greater than 5% to: - maintain hemostasis during surgical procedures and postoperatively - reduce bleeding with epi

USA - engelska - NLM (National Library of Medicine)

ferring pharmaceuticals inc. - desmopressin acetate (unii: xb13hyu18u) (desmopressin - unii:enr1llb0fp) - desmopressin 4 ug in 1 ml

USA - engelska - NLM (National Library of Medicine)

prasco laboratories - desmopressin acetate (unii: xb13hyu18u) (desmopressin - unii:enr1llb0fp) - desmopressin acetate 10 ug in 0.1 ml

USA - engelska - NLM (National Library of Medicine)

hospira, inc. - desmopressin acetate (unii: xb13hyu18u) (desmopressin - unii:enr1llb0fp) - desmopressin acetate 4 ug in 1 ml